← All companies
Kymera Therapeutics, Inc.
KYMR - CIK 0001815442
Market cap$6.44 B
Rank#1211
SEC filings575
The table below shows Kymera Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $357.01M | $120.26M | $109.97M | $68.39M | $47.98M | $31.00M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | $0.00 | $15.00M | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.